Artificial Intelligence in Drug Discovery Market by Trends, Dynamic Innovation in Technology and 2028 Forecasts

 Global Artificial Intelligence in Drug Discovery Market: Trending in 2021

 

New York, NY 15 June 2021: The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research. The report “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others); By Application; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. In 2020, the oncology segment accounted for the largest revenue share. Artificial intelligence plays an important role in the pre-diagnosis of cancer. Cancer treatments vary from person to person and personalized medicine has played an important role.

 

Artificial intelligence (AI) platforms are designed to ascertain genetic mutations, helping oncologists in designing effective treatment plans. In this line, a Switzerland-based company, Sophia Genetics developed an AI platform that helps to identify tumors by detecting genetic variations and devising personalized cancer treatment plans.

 

However, the infectious disease segment of artificial intelligence (AI) in drug discovery industry is projected to witness a lucrative growth rate over the study period. The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns. A positive scenario for the segment is also illustrated by key partnerships and collaborations in the market for artificial intelligence (AI) in drug discovery.

 

Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-sample

 

For instance, artificial intelligence (AI)-based drug discovery company, Existencia, entered into an agreement with Scripps Research to identify COVID-19 antiviral therapies. On the same ground, Google’s Deepmind company also working on the artificial intelligence (AI) platform AlphaFold. The product is designed to provide information on several proteins involved in the diagnosis of SARS and COVID-19.

 

Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.

 

In this direction, in January 2021, the U.S.-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai’s artificial intelligence (AI) platform for its pipeline oncology drug candidates.

 

Polaris Market Research has segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, and region:

Artificial Intelligence in Drug Discovery, Application Outlook (Revenue – USD Million, 2016 – 2028)

  • Drug optimization and repurposing
  • Preclinical testing
  • Others

Artificial Intelligence in Drug Discovery, Therapeutic Area Outlook (Revenue – USD Million, 2016 – 2028)

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others

 

To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-discount-pricing

 

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

 

Contact Us:

Polaris Market Research

Phone: 1–646–568–9980

Emailsales@polarismarketresearch.com

Webhttp://www.polarismarketresearch.com

Comments

Popular posts from this blog

Rail Asset Management Market: Trends, Growth, and Forecast by 2032

Biochar Market Segments, Size, Emerging Growth Factors, Top Key Players and Business Opportunities till 2028

3D Secure Payment Authentication Market: Industry Trends and Market Forecast by 2032